The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Human Immunodeficiency Virus Type 1 Mutations Selected in Patients Failing Efavirenz Combination Therapy
Open accessAbstract
Efavirenz is a potent and selective nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT). Nucleotide sequence analyses of the protease and RT genes (coding region for amino acids 1 to 229) of multiple cloned HIV-1 genomes from virus found in the plasma of patients in phase II clinical studies of efavirenz combination therapy were undertaken in order to identify the spectrum of mutations in plasma-borne HIV-1 associated with virological treatment failure. A K103N substitution was the HIV-1 RT gene mutation most frequently observed among plasma samples from patients for whom combination therapy including efavirenz failed, occurring in at least 90% of cases of efavirenz-indinavir or efavirenz-zidovudine (ZDV)-lamivudine (3TC) treatment failure. V108I and P225H mutations were observed frequently, predominantly in viral genomes that also contained other nonnucleoside RT inhibitor (NNRTI) resistance mutations. L100I, K101E, K101Q, Y188H, Y188L, G190S, G190A, and G190E mutations were also observed. V106A, Y181C, and Y188C mutations, which have been associated with high levels of resistance to other NNRTIs, were rare in the patient samples in this study, both before and after exposure to efavirenz. The spectrum of mutations observed in cases of virological treatment failure was similar for patients initially dosed with efavirenz at 200, 400, or 600 mg once a day and for patients treated with efavirenz in combination with indinavir, stavudine, or ZDV-3TC. The proportion of patients carrying NNRTI resistance mutations, usually K103N, increased dramatically at the time of initial viral load rebound in cases of treatment failure after exposure to efavirenz. Viruses with multiple, linked NNRTI mutations, especially K103N-V108I and K103N-P225H double mutants, accumulated more slowly following the emergence of K103N mutant viruses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
Studies on transformation of Escherichia coli with plasmids
Hanahan, D. (1983) · Journal of Molecular Biology · doi:10.1016/s0022-2836(83)80284-8 · Cited by 11,157
Staszewski, S., Morales-Ramirez, J., Tashima, K. T., Rachlis, A., Skiest, D., Stanford, J., Stryker, R., Johnson, P., Labriola, D. F., Farina, D., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412501 · Cited by 993
In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
Condra, J. H., Schleif, W. A., Blahy, O. M., Gabryelski, L. J., Graham, D. J., Quintero, J., Rhodes, A., Robbins, H. L., Roth, E., Shivaprakash, M., et al. (1995) · Nature · doi:10.1038/374569a0 · Cited by 974
[17] A rapid alkaline extraction method for the isolation of plasmid DNA
Birnboim, H. C. (1983) · Methods in Enzymology · doi:10.1016/0076-6879(83)00059-2 · Cited by 964
Montaner, J. S. G., Reiss, P., Cooper, D., Vella, S., Harris, M., Conway, B., Wainberg, M. A., Smith, D., Robinson, P., Hall, D., et al. (1998) · JAMA · doi:10.1001/jama.279.12.930 · Cited by 756
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy
Richman, D. D., Havlir, D., Corbeil, J., Looney, D., Ignacio, C., Spector, S. A., Sullivan, J., Cheeseman, S., Barringer, K., & Pauletti, D. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.1660-1666.1994 · Cited by 576
Hirsch, M. S., Conway, B., D'Aquila, R. T., Johnson, V. A., Brun-Vézinet, F., Clotet, B., Demeter, L. M., Hammer, S. M., Jacobsen, D. M., Kuritzkes, D. R., et al. (1998) · JAMA · doi:10.1001/jama.279.24.1984 · Cited by 563
Kozal, M. J., Shah, N., Shen, N., Yang, R., Fucini, R., Merigan, T. C., Richman, D. D., Morris, D., Hubbell, E., Chee, M., et al. (1996) · Nature Medicine · doi:10.1038/nm0796-753 · Cited by 527
Young, S. D., Britcher, S. F., Tran, L. O., Payne, L. S., Lumma, W. C., Lyle, T. A., Huff, J. R., Anderson, P. S., Olsen, D. B., & Carroll, S. S. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2602 · Cited by 482
Condra, J. H., Holder, D. J., Schleif, W. A., Blahy, O. M., Danovich, R. M., Gabryelski, L. J., Graham, D. J., Laird, D., Quintero, J. C., Rhodes, A., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8270-8276.1996 · Cited by 405
Richman, D., Shih, C. K., Lowy, I., Rose, J., Prodanovich, P., Goff, S., & Griffin, J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11241 · Cited by 393
Solid-phase reversible immobilization for the isolation of PCR products
DeAngelis, M. M., Wang, D. G., & Hawkins, T. L. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.22.4742 · Cited by 391
Smerdon, S. J., Jäger, J., Wang, J., Kohlstaedt, L. A., Chirino, A. J., Friedman, J. M., Rice, P. A., & Steitz, T. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3911 · Cited by 331
D'Aquila, R. T., Hughes, M. D., Johnson, V. A., Fischl, M. A., Sommadossi, J.-P., Liou, S.-H., Timpone, J., Myers, M., Basgoz, N., Niu, M., et al. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-12-199606150-00001 · Cited by 304
Havlir, D., Cheeseman, S. H., Mclaughlin, M., Murphy, R., Erice, A., Spector, S. A., Greenough, T. C., Sullivan, J. L., Hall, D., Myers, M., et al. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.3.537 · Cited by 298
Mutations in Retroviral Genes Associated with Drug Resistance
Mellors, J. W., Schinazi, R. F., & Larder, B. A. (1996) · Cited by 285
Larder, B. A. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2664 · Cited by 228
Starr, S. E., Fletcher, C. V., Spector, S. A., Yong, F. H., Fenton, T., Brundage, R. C., Manion, D., Ruiz, N. M., Gersten, M., Becker, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412502 · Cited by 209
Self-citationMyers, G., Korber, B., Wain-Hobson, S., Smith, R. F., & Pavlakis, G. N. (1993) · doi:10.2172/10116407 · Cited by 174
Mellors, J. W., Dutschman, G. E., Im, G., Tramontano, E., Winkler, S., & Cheng, Y. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08931-x · Cited by 132
Byrnes, V. W., Sardana, V. V., Schleif, W. A., Condra, J. H., Waterbury, J. A., Wolfgang, J., Long, W. J., Schneider, C. L., Schlabach, A. J., & Wolanski, B. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.8.1576 · Cited by 106
Demeter, L. M., Shafer, R. W., Meehan, P. M., Holden‐Wiltse, J., Fischl, M. A., Freimuth, W. W., Para, M. F., & Reichman, R. C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.794-797.2000 · Cited by 89
Carr, A., Vella, S., de Jong, M. D., Sorice, F., Imrie, A. A., Boucher, C. A., & Cooper, D. A. (1996) · AIDS · doi:10.1097/00002030-199606000-00009 · Cited by 79
Havlir, D. V., McLaughlin, M. M., & Richman, D. D. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/172.5.1379 · Cited by 62
Characterization of HIV-1 Strains Isolated from Patients Treated with TIBO R82913
Vandamme, A., Debyser, Z., Pauwels, R., de Vreese, K., Goubau, P., Youle, M. S., Gazzard, B., Stoffels, P., Cauwenbergh, G. F. M. J., Anné, J., et al. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.39 · Cited by 49
Balzarini, J. M., Pelemans, H., Esnouf, R. M., & Clercq, E. D. (1998) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1998.14.255 · Cited by 43
FRIEDLAND, G. H., Pollard, R. B., Griffith, B. P., Hughes, M. D., Morse, G. D., Bassett, R., Freimuth, W. W., Demeter, L. M., Connick, E., Nevin, T., et al. (1999) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-199908010-00005 · Cited by 42
Rübsamen‐Waigmann, H., Huguenel, E. D., Shah, A., Paessens, A., Ruoff, H. J., VONBRIESEN, H., Immelmann, A., Dietrich, U., & Wainberg, M. A. (1999) · Antiviral Research · doi:10.1016/s0166-3542(99)00010-8 · Cited by 22
Cited by
HIV-1 Antiretroviral Drug Therapy
Arts, E. J., & Hazuda, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007161 · Cited by 851
Clavel, F., & Hance, A. J. (2004) · New England Journal of Medicine · doi:10.1056/nejm2ra025195 · Cited by 800
Gulick, R. M., Ribaudo, H. J., Shikuma, C. M., Lustgarten, S., Squires, K. E., Meyer, W. A., Acosta, E. P., Schackman, B. R., Pilcher, C. D., Murphy, R. L., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031772 · Cited by 522
Palmer, S., Kearney, M., Maldarelli, F., Halvas, E. K., Bixby, C. J., Bazmi, H., Rock, D., Falloon, J., Davey, R. T., Dewar, R. L., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.406-413.2005 · Cited by 506
Population genomics of rapid adaptation by soft selective sweeps
Messer, P. W., & Petrov, D. A. (2013) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2013.08.003 · Cited by 487
Metadata
- Authors
- Bacheler, L. T., Anton, E. D., Kudish, P., Baker, D., Bunville, J., Krakowski, K., Bolling, L., Aujay, M., Wang, X. V., Ellis, D., Becker, M. F., Lasut, A. L., George, H. J., Spalding, D. R., Hollis, G., & Abremski, K.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2000-09
- Volume
- 44
- Issue
- 9
- Pages
- 2475-2484
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2117681036
- Cited by
- 268
- References
- 29
- FWCI
- 10.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.